Professor Pramod Srivastava will give a Division of Cancer Seminar on “Antigens that mediate tumor rejection”.

Prof. Pramod Srivastava is a pioneer in cancer vaccinology having developed the first personalised cancer vaccines tested in large scale clinical trials based on heatshock proteins. He has published over 200 papers in the field. He is an entrepreneur, having co-founded the company Agenus (valued >$240 million) and several others. He has published over 200 patents. He’s currently the director of the Carole and Ray Neag Comprehensive Cancer Center, and Center for Immunotherapy of Cancer and Infectious Diseases at the University of Connecticut.

Host: Dr Ehsan Ghorani

Venue: Lecture Theatre 3, Wolfson Education Centre, Hammersmith Campus

Speaker: Professor Pramod Srivastava  Ph.D., M.D, Department of Immunology, Eversource Energy Chair in Experimental Oncology. Director, Center for Immunotherapy of Cancer and Infectious Diseases. Director, Carole and Ray Neag Comprehensive Cancer Center, UCONN Health, Connecticut.

This event is open to staff and students of all faculties to attend. Please contact Maureen Francis: (m.francis@imperial.ac.uk) for link information.

If anyone would like to speak with Professor Pramod Srivastava, they should contact Ehsan Ghorani (e.ghorani@imperial.ac.uk) to make arrangements.